Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.32 EUR
15.58 M EUR
59.40 M EUR
7.99 M
About iRadimed Corporation
Sector
Industry
CEO
Roger Susi
Website
Headquarters
Winter Springs
Founded
1992
FIGI
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 46K is 50.50 EUR — it has decreased by −2.18% in the past 24 hours. Watch IRADIMED CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IRADIMED CORP stocks are traded under the ticker 46K.
46K stock has fallen by −1.20% compared to the previous week, the month change is a −0.40% fall, over the last year IRADIMED CORP has showed a 21.98% increase.
We've gathered analysts' opinions on IRADIMED CORP future price: according to them, 46K price has a max estimate of 55.09 EUR and a min estimate of 55.09 EUR. Watch 46K chart and read a more detailed IRADIMED CORP stock forecast: see what analysts think of IRADIMED CORP and suggest that you do with its stocks.
46K stock is 2.23% volatile and has beta coefficient of 1.22. Track IRADIMED CORP stock price on the chart and check out the list of the most volatile stocks — is IRADIMED CORP there?
Today IRADIMED CORP has the market capitalization of 641.27 M, it has increased by 2.18% over the last week.
Yes, you can track IRADIMED CORP financials in yearly and quarterly reports right on TradingView.
IRADIMED CORP is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
46K earnings for the last quarter are 0.39 EUR per share, whereas the estimation was 0.36 EUR resulting in a 6.17% surprise. The estimated earnings for the next quarter are 0.41 EUR per share. See more details about IRADIMED CORP earnings.
IRADIMED CORP revenue for the last quarter amounts to 16.46 M EUR, despite the estimated figure of 16.30 M EUR. In the next quarter, revenue is expected to reach 18.03 M EUR.
46K net income for the last quarter is 4.54 M EUR, while the quarter before that showed 4.58 M EUR of net income which accounts for −0.89% change. Track more IRADIMED CORP financial stats to get the full picture.
Yes, 46K dividends are paid quarterly. The last dividend per share was 0.14 EUR. As of today, Dividend Yield (TTM)% is 0.85%. Tracking IRADIMED CORP dividends might help you take more informed decisions.
IRADIMED CORP dividend yield was 0.32% in 2023, and payout ratio reached 11.10%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2024, the company has 148.00 employees. See our rating of the largest employees — is IRADIMED CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRADIMED CORP EBITDA is 19.90 M EUR, and current EBITDA margin is 31.73%. See more stats in IRADIMED CORP financial statements.
Like other stocks, 46K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRADIMED CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IRADIMED CORP technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IRADIMED CORP stock shows the strong buy signal. See more of IRADIMED CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.